(3-Chlorophenyl)(pyridin-2-yl)methanamine

Catalog No.: 
ACLWEC054
CAS No.: 
39930-15-9
Molecular Formula: 
C12H11ClN2
Molecular Weight: 
218.69
(3-Chlorophenyl)(pyridin-2-yl)methanamine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$280.00InquiryInquiry
100mg95%$407.00InquiryInquiry
250mg95%$576.00InquiryInquiry
1g95%$1684.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(3-Chlorophenyl)(pyridin-2-yl)methanamine
IUPAC Name(3-chlorophenyl)(pyridin-2-yl)methanamine
MDL No.MFCD16111891
Molecular FormulaC12H11ClN2
Molecular Weight218.69
SMILESNC(C1=CC=CC(Cl)=C1)C2=NC=CC=C2
InChI KeyAHGHYTLHTMRGLP-UHFFFAOYSA-N
Synonym(3-chlorophenyl)(pyridin-2-yl)methanamine;2-Pyridinemethanamine, α-(3-chlorophenyl)-;1-(3-Chlorophenyl)-1-(pyridin-2-yl)methanamine
CAS No.39930-15-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACLWEC054 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACVPKS865 route compound structure diagram
    ACVPKS86573742-07-1In Stock
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6In Stock
  4. Then
  5. ACLWEC054 route product structure diagram
    ACLWEC05439930-15-9
Inquiry

2. ACLWEC054 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLWEC054 route product structure diagram
    ACLWEC05439930-15-9
Inquiry

3. ACLWEC054 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLWEC054 route product structure diagram
    ACLWEC05439930-15-9
Inquiry

Comments (0)